Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $3.0 million.

  • Gossamer Bio's Other Non Operating Income fell 3111.01% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year decrease of 890.26%. This contributed to the annual value of $14.0 million for FY2024, which is 927.8% down from last year.
  • Latest data reveals that Gossamer Bio reported Other Non Operating Income of $3.0 million as of Q3 2025, which was down 3111.01% from $2.7 million recorded in Q2 2025.
  • Gossamer Bio's Other Non Operating Income's 5-year high stood at $6.5 million during Q2 2023, with a 5-year trough of -$332000.0 in Q3 2022.
  • Over the past 4 years, Gossamer Bio's median Other Non Operating Income value was $2.7 million (recorded in 2024), while the average stood at $2.6 million.
  • Per our database at Business Quant, Gossamer Bio's Other Non Operating Income soared by 113012.05% in 2023 and then crashed by 5798.41% in 2024.
  • Over the past 4 years, Gossamer Bio's Other Non Operating Income (Quarter) stood at $1.5 million in 2022, then surged by 161.54% to $3.8 million in 2023, then rose by 9.53% to $4.2 million in 2024, then decreased by 29.18% to $3.0 million in 2025.
  • Its Other Non Operating Income was $3.0 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.6 million in Q1 2025.